Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in Castration-Resistant Prostate Cancer
Ontology highlight
ABSTRACT: Illumina gene array analyses of prostate cancer cell lines that had acquired resistance to Enzalutamide (MDV3100). mRNA analyses of four cell lines (CWR-R1, LAPC-4, LNCaP, and VCAP) cells that were either untreated, treated for 48hrs with Enz (short-term), or continuously grown in Enzalutamide for >6 months.
ORGANISM(S): Homo sapiens
SUBMITTER:
Donald J Vander Griend Donald Vander Griend Steven Kregel
PROVIDER: E-GEOD-78201 | ArrayExpress | 2016-02-24
SECONDARY ACCESSION(S): GSE78201PRJNA312915
REPOSITORIES: GEO, ArrayExpress
ACCESS DATA